Extendicare Financials

Extendicare Stock Summary

Extendicare competes with Gilead Sciences, Sanofi ADR, Amgen, Merck, and Novo Nordisk. Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. Extendicare Inc. was founded in 1968 and is based in Markham, Canada. Extendicare operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.

Extendicare Key Financial Ratios

There are many critical financial ratios that Extendicare's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Extendicare reports annually and quarterly.

Extendicare Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Extendicare's current stock value. Our valuation model uses many indicators to compare Extendicare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Extendicare competition to find correlations between indicators driving Extendicare's intrinsic value. More Info.Extendicare is rated below average in return on equity category among its peers. It is rated # 4 in return on asset category among its peers reporting about  61.22  of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Extendicare's earnings, one of the primary drivers of an investment's value.

Along with financial statement analysis, the daily predictive indicators of Extendicare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Extendicare. We use our internally-developed statistical techniques to arrive at the intrinsic value of Extendicare based on widely used predictive technical indicators. In general, we focus on analyzing Extendicare Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Extendicare's daily price indicators and compare them against related drivers.

When running Extendicare's price analysis, check to measure Extendicare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Extendicare is operating at the current time. Most of Extendicare's value examination focuses on studying past and present price action to predict the probability of Extendicare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Extendicare's price. Additionally, you may evaluate how the addition of Extendicare to your portfolios can decrease your overall portfolio volatility.